InvestorsHub Logo
Followers 31
Posts 913
Boards Moderated 0
Alias Born 12/23/2009

Re: geocappy1 post# 265774

Friday, 06/03/2016 5:50:36 AM

Friday, June 03, 2016 5:50:36 AM

Post# of 346385
I also like their comment:

The company will pursue a clinical development strategy focused on conducting small, early stage studies of bavituximab in combination with I-O agents...

I understand by this that patients will be early stage in their cancer?
If so results can come faster and maybe Bavi's efficacy can be more easily tested. Hope so

Anyway I liked the PR... Their approach seems sensible and WStreet should prefer it to the uncertainty the Sunrise Halt produced
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News